What’s Ahead for Crucial Data Solutions in 2017?

2017 is slated to be an exciting year for us here at Crucial Data Solutions. Read on to learn more about upcoming system enhancements and plans for the TrialKit platform.

With 2016 now behind us, the Crucial Data Solutions team is looking forward to some exciting developments slated for this year. As we continue to cultivate customer success, here are just a few noteworthy events on the horizon in 2017:

  • Set to be released early in the first quarter, TrialKit™ will feature an iOS exclusive native mobile app that can be downloaded to build and/or manage a study or downloaded by patients to participate in a study. For the first time, clinical professionals can conduct trials from start to finish using only iOS devices – no programming expertise needed. 
  • By March, TrialKit Coder will have integrated the updated WHODrug dictionary format. This update adopts WHODrug’s new B3/C3 format, which will replace the B2 format and the C format. The B3/C3 formats are designed to meet regulatory SDTM requirements and recommendations, providing a higher level of specificity in coding.
  • Lastly, increased availability of programmable wearable technology will lead to even higher patient participation rates and greater patientricity in the healthcare industry.

Be sure to stay tuned for even more system enhancements for the TrialKit platform. Like 2016, Crucial Data Solutions anticipates record-setting growth in study creation. We expect to have an eventful and successful year as we continue to innovate clinical research technology and reduce its cost, helping to make life-changing treatments available to those who need it most.

SHARE THIS POST:
Share on linkedin
Share on twitter
Close Menu

Request a Demo

Are you interested in seeing TrialKit in action? Please complete the form below, and one of our product experts will contact you to schedule a demonstration.
By submitting this form, you agree to receive communication from Crucial Data Solutions. You may unsubscribe at any time.

We use cookies to ensure that we give you the best experience on our website.